DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
-12.43%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$367M
AUM Growth
+$367M
(-4.4%)
Cap. Flow
+$50M
Cap. Flow
% of AUM
13.63%
Top 10 Holdings %
Top 10 Hldgs %
47.4%
Holding
97
New
3
Increased
39
Reduced
15
Closed
7
Top Buys
| 1 |
SPDR S&P Biotech ETF
XBI
|
$25.5M |
| 2 |
Ascendis Pharma
ASND
|
$10.1M |
| 3 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$4.74M |
| 4 |
Adicet Bio
ACET
|
$3.21M |
| 5 |
Edgewise Therapeutics
EWTX
|
$2.7M |
Top Sells
| 1 |
Biomea Fusion
BMEA
|
$2.96M |
| 2 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$2.53M |
| 3 |
Athira Pharma
ATHA
|
$2.17M |
| 4 |
Cogent Biosciences
COGT
|
$1.67M |
| 5 |
Immunocore
IMCR
|
$1.61M |
Sector Composition
| 1 | Healthcare | 80.91% |
